NPS PHARMACEUTICALS INC (NPSP) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 370 transactions totaling $48.4M, demonstrating a bearish sentiment with -$42.7M in net insider flow. The most recent transaction on Feb 21, 2015 involved a transaction of 30,413 shares valued at $1.4M.
No significant insider buying has been recorded for NPSP in the recent period.
No significant insider selling has been recorded for NPSP in the recent period.
Based on recent SEC filings, insider sentiment for NPSP is bearish with an Insider Alignment Score of 6/100 and a net flow of -$42.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NPS PHARMACEUTICALS INC (NPSP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading NPSP stock, having executed 370 transactions in the past 90 days. The most active insider is Francois Nader (Executive), who has made 72 transactions totaling $29.6M.
Get notified when executives and directors at NPSP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 21, 2015 | P. Granadillo Pedro | Executive | Tender | 30,413 | $46.00 | $1.4M | Large |
| Feb 21, 2015 | D. Friedman Robin | Executive | Tender | 522 | $46.00 | $24.0K | |
| Feb 21, 2015 | M. Beshar Luke | Executive | Tender | 75,201 | $46.00 | $3.5M | Large |
| Feb 21, 2015 | Pauwels Eric | Executive | Tender | 30,029 | $46.00 | $1.4M | Large |
| Feb 21, 2015 | G. Groninger James | Executive | Tender | 9,188 | $46.00 | $422.6K | |
| Feb 21, 2015 | R. Selisker Rachel | Executive | Tender | 7,400 | $46.00 | $340.4K | |
| Feb 21, 2015 | Gemayel Georges | Executive | Tender | 9,000 | $46.00 | $414.0K | |
| Feb 21, 2015 | Broom Colin Md | Executive | Tender | 24,313 | $46.00 | $1.1M | Large |
| Feb 21, 2015 | E. Graf Susan | Executive | Tender | 4,761 | $46.00 | $219.0K | |
| Feb 21, 2015 | G. Tombros Peter | Executive | Tender | 57,625 | $46.00 | $2.7M | Large |
| Feb 21, 2015 | W. Bonney Michael | Executive | Tender | 13,900 | $46.00 | $639.4K | Large |
| Feb 21, 2015 | Nader Francois | Executive | Tender | 276,955 | $46.00 | $12.7M | Large |
| Feb 21, 2015 | J. Rogus Joseph | Executive | Tender | 21,663 | $46.00 | $996.5K | Large |
| Feb 21, 2015 | E. Firuta Paul | Executive | Tender | 1,114 | $46.00 | $51.2K | |
| Feb 21, 2015 | Garceau Roger | Executive | Tender | 43,349 | $46.00 | $2.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 59 | $45.6M | 49.4% |
Tender(U) | 15 | $27.8M | 30.2% |
Exercise(M) | 124 | $10.0M | 10.9% |
Payment(F) | 48 | $5.7M | 6.2% |
Purchase(P) | 54 | $2.8M | 3.1% |
Award(A) | 35 | $197.0K | 0.2% |
Other(J) | 32 | $102.2K | 0.1% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at NPS PHARMACEUTICALS INC has increased, with 31 insiders executing 370 transactions across all time. Total sales of $45.6M significantly outpace purchases of $2.8M, resulting in a net outflow of $42.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.